The following week, the hospital was buzzing with the news that Mr. Harrison’s condition had worsened significantly. He was now mostly unresponsive, and his family was reportedly furious about the lack of a definitive diagnosis. It put even more pressure on Dr. Albright, who was clearly out of her depth.
I was in the ER, consulting with Dr. Ben Carter on a routine case – a complex compound fracture that needed my assessment to determine if any underlying bone disease was present. We were reviewing X-rays, discussing treatment options. Ben, ever the professional, was focused entirely on the patient.
“Looks clean for any pathology, Anya,” he concluded, pointing to a detail on the screen. “Just a nasty fall. Lucky he didn’t hit his head.”
I nodded, making a note on the digital chart. “Agreed. Good call getting me involved though; always better to be sure with these trauma cases.”
He stretched, leaning back against the counter. “Yeah, better safe than sorry. Speaking of being sure, I was just thinking about those bio-forensic equipment upgrades you were championing a few years back. The ones for the advanced cellular analysis, if I recall?”
My ears perked up. This was precisely the kind of equipment Elara was now trying to defund, and the very suite she’d blocked me from. “Yes, the cutting-edge 3D imaging and molecular profiling system. Essential for certain rare conditions.”
“Right, that’s what I thought,” Ben mused, shaking his head. “It’s just… I remember a big push for that. There was this specific fund, a ‘legacy bio-forensic endowment’ or something like that, meant to cover exactly that kind of specialized gear for your department. The founder, Mr. Vance Senior, was quite passionate about advanced diagnostics.”
I remembered the fund. It had been established years ago, before I even joined, specifically for pioneering pathology research. “Yes, it was a generous endowment. It secured funding for the initial purchase of the first generation equipment. We were expecting a renewal to upgrade.”
Ben frowned. “That’s what’s so weird. I distinctly remember the hospital’s annual financial report, maybe six, seven years ago, mentioning that specific fund being… well, effectively emptied. ‘Reallocated due to unforeseen market volatility,’ I think the official line was.”
My breath caught in my throat. Six or seven years ago. That was precisely when Julian’s medical tech startup had imploded. The timeline matched perfectly.
“And then,” Ben continued, completely unaware of the bombshell he was dropping, “less than a year later, after Julian’s big startup failure, I saw a new line item. It wasn’t in the public hospital ledger, mind you. More like an internal financial document that crossed my desk once when I was on some committee.”
He leaned closer, lowering his voice conspiratorially, as if sharing juicy gossip rather than a crucial clue. “It was for a new ‘private research investment trust,’ unlisted and opaque, but with a substantial injection of capital. I just thought it was odd, you know? One legacy fund vanishes, another mysteriously appears right when the family needed a bailout for Julian’s mess. Felt a bit like a shell game, even if it was all legal on paper.”
My mind raced. “Unlisted and opaque,” he’d said. A “private research investment trust.” That was it. That was the missing piece. The “market volatility” wasn’t a market crash; it was Julian’s reckless speculation with Vance Research Trust funds, and Elara’s subsequent, desperate cover-up. She had drained the public-facing legacy endowment to bail out her son, then funneled money into a secret trust to keep it off the books, while maintaining the illusion of the Vance family’s financial stability.
The image of Elara’s imperious face, her disdain for me, her constant pronouncements about the family’s “legacy,” flashed through my mind. It wasn’t just about pride; it was about covering up a massive financial scandal that had jeopardized the very foundation of the hospital’s research. And now, she was willing to let patients suffer, even die, to prevent me from exposing her.
“Ben,” I said, my voice barely above a whisper, “do you remember anything else about that unlisted trust? A name, an account number, anything?”
He scratched his head. “Wish I could, Anya. It was just a glance, years ago. Just remember thinking, ‘Oh, so that’s where the old bio-forensic money went.’ But it was definitely in the Vance family’s name, or a subsidiary. And it felt… shady. Like they were trying to hide something big.”
He shrugged. “Anyway, not my department. Just an observation. So, fracture looks good?”
“Fracture looks good,” I repeated automatically, but my mind was miles away. Ben’s “accidental slip of the tongue” had just handed me the key. There was a paper trail, a financial shell game, and a motive far deeper than simple family pride. Elara wasn’t just arrogant; she was a meticulously organized fraudster, and she was risking patients’ lives to keep her secrets buried. I had to find that unlisted trust.
+ There are no comments
Add yours